I have Hep C, geno type 1, went through 66 wks of Pegasis and interferon,, level went down to zero at wk 15 but levels came back after 6 wks of stopping treatment. I am thinking about getting involved with a research study with Boceprevir and Pegasis and interferon but am concerned that I may end up with the Palcebo. Any thoughts if I should just wait for the FDA approval or go ahead and do the research drugs?